Who We Are

  • Akers Nanotechnology is a leading global rapid diagnostic test developer and supplier, and vaccine and pharmaceutical wholesaler.
  • The Company works with major suppliers and manufacturers all over the world. The current business situation for the company’s products has been challenging during the pandemic. Trade between manufacturers and customers has been difficult due to the resurgence of brokers, who act with little knowledge or know-how. Demand is high and supply chains are increasingly difficult to manage. However, Akers Nanotechnology is able to meet the needs of its customers by working with established business relationships and known and recognized companies.

Dr. Raymond F. Akers, Jr., Ph.D.

Founder and CEO of Akers

Dr. Raymond F. Akers Jr. has spent the past 35 years as an innovator in rapid diagnostic test products, and as a supplier of pharmaceuticals and vaccines. He invented the company’s products, and holds numerous patents and regulatory approvals. Dr. Akers has taken two of his companies public in the IPO process, two on the NASDAQ and one on the London Stock Exchange’s Alternative Investment Market, and has successfully closed numerous secondary offerings. He holds a doctorate in Neuroscience from Northwestern University and a B.A. in Biology from Saint Joseph’s University.

Our Team is Here to Help You

Guy Hazout

CEO Civilia SAS France WFC worldwide Sales Manager

Susan Andrelczyk

General Manager,
Regulatory And Certificates

Philippe Brisset

Legal council WFC Akers Civilia group

Ethan Levy

General Manager,
Middle East region

Rafaela

CID Brazil
Scientific Manager
South America region

Raymond F. Akers Jr., Ph.D.

CEO Akers Nanotechnology USA WFC Medical Worldwide Manager

Philippe Brisset

Legal council WFC Akers Civilia group

Ethan Levy

General Manager,
Middle East region

WELCOME TO WFC STRATEGY

 

WHO WE ARE

 

IMMUNITY TO COVID-19 TEST

 

APP WFC

 

URINE TEST KIT ANTIBODY

 

BLOOD TEST – 2 IN 1

 

CERTIFICATIONS

 

CONTACT

 

PRESS